Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison

Detalles Bibliográficos
Autores principales: Wong, Raymond, Fishman, Jesse, Wilson, Koo, Yeh, Michael, Al-Adhami, Mohammed, Zion, Abigail, Yee, Christopher W., Huynh, Lynn, Duh, Mei Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611589/
https://www.ncbi.nlm.nih.gov/pubmed/37789229
http://dx.doi.org/10.1007/s12325-023-02640-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611589/
https://www.ncbi.nlm.nih.gov/pubmed/37789229
http://dx.doi.org/10.1007/s12325-023-02640-9

Ejemplares similares